UK markets closed
  • FTSE 100

    7,017.47
    -135.96 (-1.90%)
     
  • FTSE 250

    22,324.19
    -210.95 (-0.94%)
     
  • AIM

    1,229.80
    -11.57 (-0.93%)
     
  • GBP/EUR

    1.1636
    -0.0053 (-0.46%)
     
  • GBP/USD

    1.3809
    -0.0115 (-0.83%)
     
  • BTC-GBP

    25,721.93
    -2,071.92 (-7.45%)
     
  • CMC Crypto 200

    888.52
    -51.42 (-5.47%)
     
  • S&P 500

    4,166.45
    -55.41 (-1.31%)
     
  • DOW

    33,290.08
    -533.37 (-1.58%)
     
  • CRUDE OIL

    71.50
    +0.46 (+0.65%)
     
  • GOLD FUTURES

    1,763.90
    -10.90 (-0.61%)
     
  • NIKKEI 225

    28,964.08
    -54.25 (-0.19%)
     
  • HANG SENG

    28,801.27
    +242.68 (+0.85%)
     
  • DAX

    15,448.04
    -279.63 (-1.78%)
     
  • CAC 40

    6,569.16
    -97.10 (-1.46%)
     

Managers’ transactions

  • Oops!
    Something went wrong.
    Please try again later.
·3-min read
  • Oops!
    Something went wrong.
    Please try again later.

May 27, 2021
Announcement no. 12


Managers’ transactions

BioPorto has received notification pursuant to article 19 of Regulation (EU) no. 596/2014 of the below transactions related to shares in BioPorto A/S made by persons discharging managerial responsibilities in BioPorto A/S and/or persons closely related with them.

1. Details of the person discharging managerial responsibilities/person closely associated

a) Name

Thomas Magnussen

2. Reason for the notification

a) Position/status

Chairman of the Board of Directors of BioPorto A/S

b) Initial notification/amendment

Initial notification

3. Details of the issuer

a) Name

BioPorto A/S

b) LEI

5299004SWFL5JAN4W830

4. Details of the transaction(s)

a) Description of the financial instrument, type

of instrument


Identification code

Shares




ISIN code DKDK0011048619

b) Nature of the transaction

Share sale

c) Price(s) and volume(s)

Price: DKK 3.78, Volume: 60,227

d) Aggregated information

N/A

e) Date of the transaction

2021-05-25

f) Place of the transaction

Nasdaq Copenhagen A/S, XCSE


1. Details of the person discharging managerial responsibilities/person closely associated

a) Name

Therazone ApS

2. Reason for the notification

a) Position/status

Closely associated person to Thomas Magnussen, Chairman of the Board of Directors of BioPorto A/S

b) Initial notification/amendment

Initial notification

3. Details of the issuer

a) Name

BioPorto A/S

b) LEI

5299004SWFL5JAN4W830

4. Details of the transaction(s)

a) Description of the financial instrument, type

of instrument


Identification code

Shares




ISIN code DKDK0011048619

b) Nature of the transaction

Share sale

c) Price(s) and volume(s)

Price: DKK 3.78, Volume: 191,621

d) Aggregated information

N/A

e) Date of the transaction

2021-05-25

f) Place of the transaction

Nasdaq Copenhagen A/S, XCSE


1. Details of the person discharging managerial responsibilities/person closely associated

a) Name

Thomas Magnussen

2. Reason for the notification

a) Position/status

Chairman of the Board of Directors of BioPorto A/S

b) Initial notification/amendment

Initial notification

3. Details of the issuer

a) Name

BioPorto A/S

b) LEI

5299004SWFL5JAN4W830

4. Details of the transaction(s)

a) Description of the financial instrument, type

of instrument


Identification code

Shares




ISIN code DKDK0011048619

b) Nature of the transaction

Share sale

c) Price(s) and volume(s)

Price: DKK 3.52, Volume: 128,344

d) Aggregated information

N/A

e) Date of the transaction

2021-05-26

f) Place of the transaction

Nasdaq Copenhagen A/S, XCSE


1. Details of the person discharging managerial responsibilities/person closely associated

a) Name

Therazone ApS

2. Reason for the notification

a) Position/status

Closely associated person to Thomas Magnussen, Chairman of the Board of Directors of BioPorto A/S

b) Initial notification/amendment

Initial notification

3. Details of the issuer

a) Name

BioPorto A/S

b) LEI

5299004SWFL5JAN4W830

4. Details of the transaction(s)

a) Description of the financial instrument, type

of instrument


Identification code

Shares




ISIN code DKDK0011048619

b) Nature of the transaction

Share sale

c) Price(s) and volume(s)

Price: DKK 3.52, Volume: 408,379

d) Aggregated information

N/A

e) Date of the transaction

2021-05-26

f) Place of the transaction

Nasdaq Copenhagen A/S, XCSE

For further information, please contact:

Karen Stendal, Legal Counsel
Telephone +45 4529 0000, e-mail: investor@bioporto.com

About BioPorto
BioPorto is an in vitro diagnostics company that provides tests and antibodies to clinicians and researchers around the world. We use our antibody and assay expertise to transform novel research tools into clinically actionable biomarkers that can make a difference in patients’ lives. BioPorto is headquartered in Hellerup, Denmark and is listed on the NASDAQ Copenhagen stock exchange [CPH:BIOPOR].

Attachment


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting